Marathon of Hope Cancer Centres Network’s Post

The goal of #PrecisionOncology is to improve outcomes and quality of life for cancer patients by providing the right treatment at the right time for each patient. But it's clear that there's still a lot of work to do before this is possible for every patient and every cancer. As we work towards that goal, it is important to understand that #precisiononcology is also about knowing if a drug will NOT work for a certain patient population and what side-effects taking that drug may have. This knowledge empowers patients to make treatment decisions based on their own values. Dr. Laura Hopkins is working on a clinical trial aimed at measuring this very element in patients with #ovariancancer in #Saskatchewan. We spoke to Dr. Hopkins to better understand why this type of research is important, and how the Marathon of Hope Cancer Centres Network is taking a multi-pronged approach to advance precision medicine for more cancer patients in Canada by supporting projects like this. #TeamCanadaOfCancerResearch

The IU Simon Comprehensive Cancer Center is taking on lung cancer from every angle. The Tom and Julie Wood Center for Lung Cancer Research was established in March 2024 with a $20 million gift from Julie Wood. The gift honors her late husband, Tom Wood, the well-known Indianapolis auto executive who died of lung cancer in 2010. The newly established center will expand efforts in basic science research to understand the complexities of lung cancer at a cellular level, guide the development of innovative lung cancer drugs, support early-phase clinical trials for IU-developed treatments, and expand the lung cancer precision genomics program. Learn more: https://ow.ly/hXYh50QWABw. #ResearchCuresCancer | Indiana University School of Medicine | Indiana University Research

On World Breast Cancer Research Day, we honor the incredible strength and resilience of those affected by breast cancer and reaffirm our commitment to advancing research in this critical field. At SHRO, our scientists are at the forefront of discovering new treatment strategies and understanding the molecular mechanisms that drive breast cancer. Every breakthrough brings us closer to a world where breast cancer is no longer a threat. Join us in supporting the vital research that offers hope and healing to millions. Together, we can make a difference. Check out our most recent blog on how artificial intelligence is transforming the screening and diagnosis of breast cancer Link to the Italian blog: https//bit.ly/4bO7aPF Link to the English Blog: https://bit.ly/3Y8PZp5 www.drantoniogiordano.com | www.shro.org Antonio Giordano Sbarro Health Research Organization Temple University Università di Siena #BreastCancerResearchDay #CancerResearch #HopeForACure #SHRO #WorldBreastCancerResearchDay #BreastCancerAwareness #BreastCancerResearch #FindACure #HopeForACure #CancerResearch #SupportTheFight #EndBreastCancer #SHROResearch #TogetherWeCan #BreastCancerSurvivors #ResearchForHope

A research team led by Dr Lisa Mielke at La Trobe's School of Cancer Medicine, the Olivia Newton-John Cancer Research Institute, have made a discovery that holds great potential for treating one of the world's most prominent forms of cancer. The team found that patients whose bowel cancer tumours showed evidence of a particular type of immune cell (known as a 'gamma delta t-cell') had much better health outcomes. This led researchers to take a closer look at gamma delta t-cells to better understand how to harness and enhance their cancer-killing potential. The research - shortlisted for a prestigious Australian Museum Eureka Prize for Scientific Resarch - may pave the way for new immunotherapies that improve health outcomes and save the lives of countless cancer patients. Learn more: https://lnkd.in/gxzmbHh5 #cancer #medicalresearch #latrobeuni #onjcri

New in JCO Global Oncology! This issue supplement highlights 136 scientific abstracts from the 12th Annual Symposium on Global Cancer Research (ASGCR), featuring cancer research conducted in over 65 countries. Additionally, the ASGCR Steering Committee reflects on the importance of equitable collaborations in global cancer research, in the accompanying editorial. Read more 🔗 https://go.nih.gov/VqEH27q. American Society of Clinical Oncology (ASCO), American Association for Cancer Research, AFRICAN ORGANIZATION FOR RESEARCH AND TRAINING IN CANCER AORTIC INC, American Society of Preventive Oncology, Consortium of Universities for Global Health, TATA MEMORIAL HOSPITAL, & Red de Institutos Nacionales de Cáncer/Sociedad Latino Americana y del Caribe De Oncología Médica (RINC-SLACOM) #CancerResearch #CancerControl #GlobalHealth

Danube Private University Austria (DPU) announces new co-operation with the European Organization for Research and Treatment of Cancer (EORTC) The EORTC, based in Brussels, is an independent, non-governmental, non-profit cancer research organization whose mission is to coordinate and conduct international, translational and clinical research to improve the standard of cancer treatment for patients. Prof. Dr. Julia Furtner-Srajer ,PhD, MBA from the Danube Private University's Research Center for Medical Image Analysis and Artificial Intelligence (MIAAI) is leading the new research co-operation with the topic of sarcopenia in glioblastoma patients. For more information about current research projects and to view recent publications from the DPU please visit: https://lnkd.in/dQ6rNp7q #medicine #research #healthcare #diagnostics #clinicalresearch #patientcare #cancercare #oncology #cancer #braincancer #glioblastoma #sarcopenia #wienerneustadt #niederoesterreich #austria #danubeprivateuniversity

For our third part in the ASCO recap highlighting NFCR-associated scientists, we are highlighting Himisha Beltran, M.D. On June 3rd, during the Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers session, Dr. Beltran presented an update on her research study targeting T-cell engagers in patients with small cell lung cancer and other neuroendocrine cancers. Dr. Beltran’s research is yielding tremendous results. We look forward to continuing our support of her groundbreaking research! To help make cures possible and continue the work that these excellent researchers are doing, visit https://lnkd.in/egA25rnh #NFCR #makecurespossible #cancerresearch #cancer #research #cancerresearcher #researchscientists #breakthrough #cancertreatment #fightcancer #beatcancer #curecancer #cancerfree #cancersupport #cancervurvivor #cancerawareness Harvard Medical School Dana-Farber Cancer Institute

Game-changing news in rare cancer research! 🔬 Researchers from the International Agency for Research on Cancer have achieved a groundbreaking milestone in understanding rare cancers. They've developed "mini-tumours," a revolutionary tool that mirrors the complexity of rare cancers in a controlled environment. This innovation offers a new window into cancer progression and opens up possibilities for designing more effective clinical interventions. Why is this important? These mini-tumours preserve the unique characteristics of the original tumors, allowing researchers to study them in unprecedented detail. This means a better understanding of how rare cancers evolve and respond to treatments, bringing us closer to personalized medicine for those facing these challenging diagnoses. Your ongoing support and interest are what drive these scientific breakthroughs! Together, let's continue to make strides in rare cancer research and care. 🌟 Read more about this incredible advancement here: https://lnkd.in/gd63a_Wb #RareCancerResearch #Innovation #MiniTumours #JediRareCancerFoundation #RaiseAwareness #MakingADifference #DonateToday #FightAgainstRareCancers #RareCancerIsntRare

This Sunday, February 4th is World Cancer Day, an initiative of the Union for International Cancer Control (UICC) to take action to promote health equity, enhance cancer service accessibility, and #CloseTheCareGap. Visit their website to learn more and sign the call to action! --> https://lnkd.in/dYiwh8xA Bruker’s fluorescent microscopes are used in labs around the world working to better understand the mechanisms underlying various forms of cancer. Specific applications include the Ultima multiphoton system being used to investigate anti-tumor immunity in poor prognosis cancers or the Luxendo InVi SPIM light-sheet system helping to unravel breast cancer evolution and potential treatments. ⬇️Characterization and imaging of stochastic tumorigenesis in mammary organoids. #WorldCancerDay #CancerResearch #CancerAwareness

Excited to see our latest manuscript published in Current Oncology MDPI! Our analysis of the National Cancer Database, in which we attempted to control for multiple confounding factors through inverse probability of treatment weight (IPTW), indicated, among others, that: • Non-Hispanic Black patients were 12% more likely to undergo resection of a locally advanced rectal cancer with positive margins compared to non-Hispanic White patients. • Patients treated in the northeastern United States were 9% less likely to have positive margins compared to those treated in the south. • Patients treated in academic/research centers were 11% less likely to have positive margins compared to to those treated in community cancer programs. Find out more following the link to our manuscript: https://lnkd.in/ecFVSFnD I would like to thank my mentor Dr. Jose Guillem for the guidance, support and the opportunity. Shoutout to Drs. William Luo, Chris B. Agala, PhD, Jonathan Stem, and Lydia Comer for this wonderful collaborative effort. #disparities #rectalcancer #LARC #NCDB